[HTML][HTML] Post-COVID-19 symptom burden: what is long-COVID and how should we manage it?

…, N Jawad, P Gunasekera, AH Morice, MG Crooks - Lung, 2021 - Springer
The enduring impact of COVID-19 on patients has been examined in recent studies, leading
to the description of Long-COVID. We report the lasting symptom burden of COVID-19 …

Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 …

…, R Djukanovic, TMA Wilkinson, MG Crooks… - The Lancet …, 2021 - thelancet.com
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection carries
a substantial risk of severe and prolonged illness; treatment options are currently limited. …

[HTML][HTML] A proposal for multidisciplinary tele-rehabilitation in the assessment and rehabilitation of COVID-19 survivors

A Salawu, A Green, MG Crooks, N Brixey… - International journal of …, 2020 - mdpi.com
A global pandemic of a new highly contagious disease called COVID-19 resulting from
coronavirus (severe acute respiratory syndrome (SARS)-Cov-2) infection was declared in …

Impact of COVID-19 on COPD and asthma admissions, and the pandemic from a patient's perspective

…, S Faruqi, L Holdsworth, MG Crooks - Erj Open …, 2021 - Eur Respiratory Soc
The coronavirus disease 2019 (COVID-19) pandemic has led to an overall reduction in
hospital admissions in the United Kingdom (UK) with national data showing a decline in …

[HTML][HTML] STIMULATE-ICP: A pragmatic, multi-centre, cluster randomised trial of an integrated care pathway with a nested, Phase III, open label, adaptive platform …

…, A Green, E Attree, L Hismeh, WD Strain, MG Crooks… - PloS one, 2023 - journals.plos.org
Introduction Long COVID (LC), the persistent symptoms ≥12 weeks following acute COVID-19,
presents major threats to individual and public health across countries, affecting over 1.5 …

[HTML][HTML] STIMULATE-ICP-Delphi (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated …

…, J Sweetman, G Allsopp, E Attree, MG Crooks… - Plos one, 2022 - journals.plos.org
Introduction As mortality rates from COVID-19 disease fall, the high prevalence of long-term
sequelae (Long COVID) is becoming increasingly widespread, challenging healthcare …

Coagulation and anticoagulation in idiopathic pulmonary fibrosis

MG Crooks, SP Hart - European respiratory review, 2015 - Eur Respiratory Soc
Idiopathic pulmonary fibrosis (IPF) is an incurable, progressive interstitial lung disease with
a prognosis that is worse than that of many cancers. Epidemiological studies have …

[HTML][HTML] Evidence generation for the clinical impact of myCOPD in patients with mild, moderate and newly diagnosed COPD: a randomised controlled trial

MG Crooks, J Elkes, W Storrar, K Roy… - ERJ open …, 2020 - Eur Respiratory Soc
Self-management interventions in COPD aim to improve patients9 knowledge, skills and
confidence to make correct decisions, thus improving health status and outcomes. myCOPD is …

Serum carcinoembryonic antigen correlates with severity of idiopathic pulmonary fibrosis

A Fahim, MG Crooks, R Wilmot, AP Campbell… - …, 2012 - Wiley Online Library
Background and objective: Idiopathic pulmonary fibrosis (IPF) is the commonest idiopathic
interstitial pneumonia and carries a poor prognosis. Epidemiological evidence suggests that …

[HTML][HTML] Environmental sustainability in respiratory care: an overview of the healthCARe-Based envirONmental Cost of Treatment (CARBON) programme

…, N Budgen, A Menzies-Gow, J Bell, MG Crooks - Advances in …, 2022 - Springer
Introduction Faced with the challenges of climate change, countries are seeking to decarbonise
their economies. A greater understanding of what comprises the carbon footprint of care …